Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4) Journal Article
| Authors: | Morales, A.; Kamat, A.; Steinberg, G.; Given, R.; Amrhein, J.; Cohen, Z.; Herr, H. |
| Article Title: | Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4) |
| Keywords: | cancer survival; treatment outcome; unclassified drug; cancer recurrence; disease free survival; antineoplastic agent; prospective study; letter; bcg vaccine; progression free survival; cohort analysis; antineoplastic activity; cancer resistance; statistical significance; muscle metastasis; sample size; recurrence free survival; lamina propria; non muscle invasive bladder cancer; human; priority journal; mycobacterium phlei cell wall nucleic acid complex |
| Journal Title: | Urologic Oncology: Seminars and Original Investigations |
| Volume: | 33 |
| Issue: | 8 |
| ISSN: | 1078-1439 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-08-01 |
| Start Page: | 335 |
| End Page: | 336 |
| Language: | English |
| DOI: | 10.1016/j.urolonc.2015.05.010 |
| PROVIDER: | scopus |
| PUBMED: | 26182846 |
| DOI/URL: | |
| Notes: | Export Date: 2 September 2015 -- Source: Scopus |
